TP Ther­a­peu­tics grabs $80M mez­za­nine round to fund a piv­otal tri­al for ROS-1/NTRK-pos­i­tive can­cers

San Diego-based TP Ther­a­peu­tics is en­joy­ing the ris­ing flow of cash be­ing di­rect­ed to start­up biotechs — par­tic­u­lar­ly when they are de­vot­ed to on­col­o­gy. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER